Skip to main content

CHIRON CAPITAL MANAGEMENT, LLC

Position in BMY — Bristol Myers Squibb Co

CIK 1830922 TALLAHASSEE, FL

Position in BMY

as of Jun 30, 2026 · filed Jul 21, 2026
Position Value
$11,925,611
+$323,994 QoQ
Shares Held
206,970
+8.2% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
11.86%
of 13F equity value
Holder Rank
#370
of 2,506 holders
Holding Since
Sep 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BMY Over Time

Shares Held

Position Value (USD)

Derivatives in BMY

reported options exposure · as of Sep 30, 2020
CallValue
$2,000
CallShares
200
PutValue
$6,000
PutShares
2,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

CHIRON CAPITAL MANAGEMENT, LLC holds $16,063,883 across 6 Drug Manufacturers - General names. BMY ranks #1 (74.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BMY
Bristol Myers Squibb Co
This page
206,970 $11,925,611

All Filings in BMY

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $11,925,611 206,970
2026-03-31 $11,601,617 191,288
2025-09-30 $12,780,122 283,373
2025-06-30 $13,258,057 286,413
2025-03-31 $18,273,091 299,608
2024-12-31 $23,162,903 409,528
2024-09-30 $23,003,914 444,606
2024-06-30 $18,787,507 452,384
2024-03-31 $24,225,625 446,720
2023-12-31 $22,813,195 444,615
2023-09-30 $27,261,968 469,710
2023-06-30 $30,611,138 478,673
2023-03-31 $33,070,226 477,135
2022-12-31 $34,978,348 486,148
2022-09-30 $37,118,861 522,139
2022-06-30 $41,364,169 537,197
2022-03-31 $45,134,000 618,020
2021-12-31 $44,500,192 713,716
2021-09-30 $42,252,468 714,086
2021-06-30 $44,373,959 664,082
2021-03-31 $48,297,795 765,053
2020-12-31 $47,916,128 772,467
2020-09-30 $6,000 2,100
2020-09-30 $47,272,122 784,079
2020-09-30 $2,000 200